WMSA
ACOR

Weiss Multi-Strategy Advisers’s Acorda Therapeutics ACOR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-57
Closed -$257K – 978
2014
Q1 		$257K Buy
+57
New +$230K 0.01% 862

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ACOR Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of Acorda Therapeutics (ACOR) in Q2 2014, closing a stake of 57 shares — an estimated $257K sold.

Weiss Multi-Strategy Advisers first reported a position in ACOR in Q1 2014 and held it in 1 quarter. The position peaked at $257K in Q1 2014. 162 funds tracked by Wall St. Rank hold ACOR as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Acorda Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 57 Acorda Therapeutics shares in Q2 2014, an estimated $257K.
  • Weiss Multi-Strategy Advisers first reported a position in Acorda Therapeutics in Q1 2014 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Acorda Therapeutics position peaked at $257K in Q1 2014.
  • 162 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.